Background: Although, metabolic syndrome and obesity are cardiovascular risk factors, little systematically collected community-based data are available from the Arabian Gulf region. Methods: We report a nationwide cross-sectional study from Kuwait. A random sample was selected. Demographic and clinical data were collected. Blood tests including fasting blood glucose, high-density lipoprotein cholesterol, and triglycerides were collected. Metabolic syndrome was defined according to International Diabetes Federation criteria. Overweight and obesity were defined as body mass index ≥25, and body mass index ≥30, respectively. Results: Prevalence of overweight, obesity, and metabolic syndrome in adult Kuwaiti population were 80.4%, 47.5%, and 36.2%, respectively. Overweight and obesity rates were higher in women 81.9% and 53% compared to men 78% and 39.2%, respectively (P = .02, P > .001). MetS was equally distributed between men and women at 36.2% and 36.1%. Conclusions: Prevalence of overweight, obesity, and metabolic syndrome is alarmingly high in Kuwait. This requires urgent and active community-based public health intervention.
Sanderson JE , Mayosi B., Yusuf S., et al. Global burden of cardiovascular disease . Heart. 2007;93:1175.
2.
Yusuf S., Ounpuu S.Tackling the growing global burden of atherosclerotic cardiovascular diseases . Eur J Cardiovasc Prev Rehabil. 2003;10:236-239.
3.
Yusuf S., Reddy S., Ounpuu S., Anand S.Global burden of cardiovascular diseases: part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies . Circulation. 2001;104: 2855-2864.
4.
Yusuf S., Reddy S., Ounpuu S., Anand S.Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104:2746-2753.
5.
Cameron AJ, Shaw JE, Zimmet PZThe metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am. 2004;33:351-375, Table of contents.
6.
Yusuf S., Vaz M., Pais P.Tackling the challenge of cardiovascular disease burden in developing countries . Am Heart J. 2004;148:1-4.
7.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
8.
Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-689.
9.
Alberti KG, Zimmet P., Shaw J.Metabolic syndrome-a new world-wide definition.A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23:469-480.
10.
Magliano DJ, Shaw JE, Zimmet PZHow to best define the metabolic syndrome. Ann Med. 2006;38:34-41.
11.
Yusuf S., Hawken S., Ounpuu S., et al; INTERHEART Study Investigators.Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366:1640-1649.
12.
Sorkhou EI, Al-Qallaf B., Al-Namash HA, Ben-Nakhi A., Al-Batish MM, Habiba SAPrevalence of metabolic syndrome among hypertensive patients attending a primary care clinic in Kuwait. Med Princ Pract. 2004 ;13:39-42.
13.
Bonita R., deCourteb M., Dwyer T., Jamrozik K., Winkelmann R.Surveilance of risk factors for noncommunicable disease: the WHO STEPwise approach. World Health Organization; 2002 WHO document WHO/ NMH/CCS/01.2002: Geneva; 2002.
14.
Romero-Corral A., Montori VM, Somers VK, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006;368:666-678.
15.
Zimmet P., MM Alberti KG, Serrano Rios M.[A new international diabetes federation worldwide definition of the metabolic syndrome: the rationale and the results]. Rev Esp Cardiol . 2005;58:1371-1376.
16.
Athyros VG, Ganotakis ES, Elisaf M., Mikhailidis DPThe prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions. Curr Med Res Opin. 2005;21:1157-1159.
17.
Milionis HJ , Filippatos TD, Derdemezis CS, et al. Excess body weight and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects. Eur J Neurol. 2007;14: 762-769.
18.
Milionis HJ , Kostapanos MS, Liberopoulos EN, et al. Different definitions of the metabolic syndrome and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects. Int J Clin Pract. 2007;61:545-551.
19.
Ismail MN, Chee SS, Nawawi H., Yusoff K., Lim TO, James WPObesity in Malaysia. Obes Rev. 2002;3: 203-208.
20.
Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CLOverweight and obesity in the United States: prevalence and trends, 1960-1994 . Int J Obes Relat Metab Disord. 1998;22:39-47.
21.
Moon OR, Kim NS, Jang SM, Yoon TH, Kim SOThe relationship between body mass index and the prevalence of obesity-related diseases based on the 1995 National Health Interview Survey in Korea. Obes Rev. 2002;3:191-196.
22.
Tan CE, Emmanuel SC, Tan BY, Jacob E.Prevalence of diabetes and ethnic differences in cardiovascular risk factors. The 1992 Singapore National Health Survey. Diabetes Care. 1999;22:241-247.
23.
Zhou BFEffect of body mass index on all-cause mortality and incidence of cardiovascular diseases-report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults. Biomed Environ Sci. 2002;15:245-252.
24.
Deedwania P. , Barter P., Carmena R., et al. Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study. Lancet. 2006;368: 919-928.
